Article

Trends in the Use of Standardized Tools for Developmental Screening in Early Childhood: 2002-2009

Department of Research, American Academy of Pediatrics, 141 Northwest Point Blvd, Elk Grove Village, IL 60007, USA. .
PEDIATRICS (Impact Factor: 5.47). 06/2011; 128(1):14-9. DOI: 10.1542/peds.2010-2180
Source: PubMed

ABSTRACT

Early identification of developmental delays is essential for optimal early intervention. An American Academy of Pediatrics (AAP) 2002 Periodic Survey of Fellows found <25% of respondents consistently used appropriate screening tools. Over the past 5 years, new research and education programs promoted screening implementation. In 2006, the AAP issued a revised policy statement with a detailed algorithm. Since the 2002 Periodic Survey, no national surveys have examined the effectiveness of policy, programmatic, and educational enhancements.
The goal of this study was to compare pediatricians' use of standardized screening tools from 2002 to 2009.
A national, random sample of nonretired US AAP members were mailed Periodic Surveys (2002: N=1617, response rate: 55%; 2009: N=1620, response rate: 57%). χ(2) analyses were used to examine responses across survey years; a multivariate logistic regression model was developed to compare differences in using ≥1 formal screening tools across survey years while controlling for various individual and practice characteristics.
Pediatricians' use of standardized screening tools increased significantly between 2002 and 2009. The percentage of those who self-reported always/almost always using ≥1 screening tools increased over time (23.0%-47.7%), as did use of specific instruments (eg, Ages & Stages Questionnaire, Parents' Evaluation of Developmental Status). No differences were noted on the basis of physician or practice characteristics.
The percentage of pediatricians who reported using ≥1 formal screening tools more than doubled between 2002 and 2009. Despite greater attention to consistent use of appropriate tools, the percentage remains less than half of respondents providing care to patients younger than 36 months. Given the critical importance of developmental screening in early identification, evaluation, and intervention, additional research is needed to identify barriers to greater use of standardized tools in practice.

Full-text preview

Available from: pediatrics.aappublications.org
    • "It also is of concern that the USPSTF statement noted that there are few studies of the prevalence of screening for ASD. Five papers in the past decade have surveyed physicians about screening practices (Arunyanart et al. 2012;Dosreis et al. 2006;Gillis 2009;Radecki et al. 2011;Zuckerman et al. 2013), and four of these have specifically asked about ASD screening (Arunyanart et al. 2012;Dosreis et al. 2006;Gillis 2009;Zuckerman et al. 2013). Physicians reported far from universal use of broad developmental screening tools (41–82 %) and ASDspecific screening tools (8–59 %) during well-child visits. "

    No preview · Article · Jan 2016 · Journal of Autism and Developmental Disorders
  • Source
    • "In the USA, the use of standardized developmental screening tools has significantly increased in the last few years. From 2002 to 2009, the instruments with highest increase of use were the Ages and Stages Questionnaire (ASQ, from 13% to 40%) and the Parents Evaluation of Developmental Status (PEDS, from 8% to 29%) [6]. While the PEDS directly elicits parents' concern regarding the development and behavior of their children through open questions [7], the ASQ asks parents to observe and report the achievement of observable skills or behaviors of their children using structured and concrete questions [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To validate the translated and cross culturally adapted Chilean version of the 8 and 18month Ages and Stages Questionnaire (ASQ-CL) in a community sample. Methods: Participants: Parents of 1572 term children (82.9%) and 324 children at risk for developmental delay (17.1%) were included. Instrument: ASQ-3rd edition translated and culturally adapted for Chilean urban population. Main measures: 8 and 18months ASQ-CL reliability, validity and mean scores. Feasibility was assessed using qualitative methods in healthcare professionals and mothers. Results: ASQ-CL mean scores were comparable to U.S. normative data. The overall total score and all domains were reliable (Cronbach alpha 0.66-0.85). Test-retest and inter-rater reliability were high (Pearson's r range 0.73-0.94; intraclass correlation r range 0.68-0.93). Early preterm infants were more likely to fail on several criteria. Qualitative methods confirmed ASQ-CL as a feasible tool in this Chilean urban community. Conclusions: ASQ-CL is a valid, reliable and feasible tool for assessing development in children at 8 and 18months in Chilean urban population.
    Full-text · Article · Dec 2015 · Early Human Development
  • Source
    • "However, the U.S. Preventive Services Task Force (2013) deemed that evidence is insufficient to recommend for or against screening and counseling for youth SU. Pediatrician use of standardized screening tools for developmental delays has recently increased (Radecki et al., 2011) whereas using standardized tools for risk of behavior problems has lagged (Jee et al., 2011; Kelleher and Stevens, 2009). Reasons for their reluctance include practice burden (time, staffing cost), unfamiliarity with treatment resources for referral, high false-positive rates of screens, and fear of alienating patients or parents with queries about sensitive behaviors (Van Hook et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Youth substance use (SU) is prevalent and costly, affecting mental and physical health. American Academy of Pediatrics and Affordable Care Act call for SU screening and prevention. The Youth Risk Index(©) (YRI) was tested as a screening tool for having initiated and propensity to initiate SU before high school (which forecasts SU disorder). YRI was hypothesized to have good to excellent psychometrics, feasibility and stakeholder acceptability for use during well-child check-ups. A high-risk longitudinal design with two cross-sectional replication samples, ages 9-13 was used. Analyses included receiver operating characteristics and regression analyses. A one-year longitudinal sample (N=640) was used for YRI derivation. Replication samples were a cross-sectional sample (N=345) and well-child check-up patients (N=105) for testing feasibility, validity and acceptability as a screening tool. YRI has excellent test-retest reliability and good sensitivity and specificity for concurrent and one-year-later SU (odds ratios=7.44, CI=4.3-13.0) and conduct problems (odds ratios=7.33, CI=3.9-13.7). Results were replicated in both cross-sectional samples. Well-child patients, parents and pediatric staff rated YRI screening as important, acceptable, and a needed service. Identifying at-risk youth prior to age 13 could reap years of opportunity to intervene before onset of SU disorder. Most results pertained to YRI's association with concurrent or recent past risky behaviors; further replication ought to specify its predictive validity, especially adolescent-onset risky behaviors. YRI well identifies youth at risk for SU and conduct problems prior to high school, is feasible and valid for screening during well-child check-ups, and is acceptable to stakeholders. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    Full-text · Article · Mar 2015 · Drug and Alcohol Dependence
Show more